Coverage debates frequently return to scheduling and bans. India and America the two face variations of precisely the same issue: whether to impose broader, course-large controls above fentanyl analogs as well as their precursors, or to maintain material-by-substance scheduling that may lag powering traffickers’ innovation.India’s legal framewo